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 Chronic exposure of mammals to low dose-rates of ionizing radiation affects prolifer-
ating cell systems as a function of both dose-rate and the total dose accumulated. The
lower the dose-rate the higher needs to be the total dose for a deterministic effect, i.e., tis-
sue reaction to appear. Stem cells provide for proliferating, maturing and functional cells.
Stem cells usually are particularly radiosensitive and damage to them may propagate to
cause failure of functional cells. The paper revisits 1) medical histories with emphasis on
the hemopoietic system of the victims of ten accidental chronic radiation exposures, 2)
published hematological findings of long-term chronically gamma-irradiated rodents, and
3) such findings in dogs chronically exposed in large life-span studies. The data are con-
sistent with the hypothesis that hemopoietic stem and early progenitor cells have the
capacity to tolerate and adapt to being repetitively hit by energy deposition events. The
data are compatible with the “injured stem cell hypothesis”, stating that radiation–injured
stem cells, depending on dose-rate, may continue to deliver clones of functional cells that
maintain homeostasis of hemopoiesis throughout life. Further studies perhaps on sepa-
rated hemopoietic stem cells may unravel the molecular-biology mechanisms causing radi-
ation tolerance and adaptation.
Keywords: chronic irradiation, hemopoietic tolerance, stem cell adaptation
INTRODUCTION
The patho-physiology in acutely irradiated mammals was first sum-
marized in the seminal monograph by Victor P. Bond, John O.
Archambeau and T.M. Fliedner, published in 1965; its title is “Mammalian
Radiation Lethality – A Disturbance in Cellular Kinetics” (Bond et al.
1965). This monograph also presents the then available and still today rel-
evant knowledge regarding the pathogenesis of the hemopoietic syn-
dromes that develop after acute radiation exposure to varying doses.
The current contribution addresses the effects of chronic radiation
exposure on hemopoiesis, by referring to some previously published rep-
Address correspondence to L.E. Feinendegen, Phone + 49 (0)8382 75673; Fax: + 49
(0)8382 947626; Email: feinendegen@gmx.net
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resentative data on low dose-rate induced responses in the hemopoietic
system. This data was obtained mainly in rats and dogs and in reports on
a number of radiation accidents (for summary: Fliedner et al. 2002a). It
emerges that, in line with early observations (Lamerton et al. 1960), the
relationship between daily low-dose level exposures and clinical signs and
symptoms in the exposed organisms is determined by the damage accu-
mulating especially in the rapidly turning over cell renewal systems – such
as the hemopoietic tissue. This means that the tissue effect of hemopoi-
etic failure depends on both total absorbed dose, in short dose, and on
the dose-rate or frequency of repetitive exposures.
During continuous exposures of tissues individual and defined micro-
masses in the exposed tissues experience at certain time intervals energy
deposition events (hits) from charged particle tracks. The dose values,
i.e., sizes, of these hits depend on the size of the micromass and the ener-
gy spectrum provided by the given radiation quality (ICRU, 1983). The
longer the time interval between consecutive hits in a given individual
micromass, such as a cell, the longer is the time for the hit cell to respond
to the previous hit without disturbance from a second hit. Thus, dose-rate
effects depend on both, the spectrum of hit sizes and of the time inter-
vals between consecutive hits. Indeed, experimental evidence with low-
LET radiation exposures speaks in favor of low dose-rates being less effi-
cient per total dose to cause tissue effects than high dose-rates or single
exposures. This also complies with theoretical analyses (Scott 1980, Scott
et al. 1988; Kutkov et al. 2011). The more damage from individual hits is
allowed to accumulate, the lower is the total dose needed for the tissue
effect to occur.
The analysis of the revisited data focuses on the responses of hemo-
poietic stem cells regarding their potential of tolerance and adaptation in
the course of being chronically exposed to different dose-rates. Stem cells
are pluripotential or committed and divide upon demand in a cascade of
signaling in order to provide for functioning cells through repetitive cell
divisions of differentiating cells and cell maturation. In mammalian
hemopoiesis, the time of cell differentiation and maturation to deliver
fully functional cells is species specific and ranges over several days up to
about one week (Bond et al.1965). Even if hemopoietic stem cells are gen-
erally rather radiosensitive, they are not necessarily the most radiosensi-
tive cells. Thus, especially some progenitor cells in the GI-tract (Potten
and Hendry 1995) and testes (Oakberg 1971) can be far more radiosen-
sitive than hemopoietic stem cells. Differences amongst hemopoietic pro-
genitor cells with some being rather radioresistant have also been seen
(Baird et al. 1990; Bierkens et al. 1991; Fliedner et al. 2002c). For instance,
marrow repopulating ability was more radioresistant to gamma-radiation
than were spleen colony-forming cells (Fliedner et al. 2002c). However,
despite the ranges of individual stem cell responses to radiation, the
Dose response, hemopoietic stem cells, adaptive protection
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hemopoietic cell system in mammals is generally more radiosensitive
than the GI cell system or skin. These graded system differences in
radiosensitivities are the reason for the hemopoietic failure to occur at
doses lower than the doses that cause the GI-tract failure or acute skin
damage. At very low dose-rates, the total dose that is needed to bring
about the tissue effect of hemopoietic failure reaches very high values, so
that at low dose-rates hemopoiesis continues to fully function clinically up
to very high total doses, as is explained also theoretically (Scott 1980;
Scott et al. 1988, Kutkov et al. 2011). Thus, both total dose and dose-rates
need consideration in evaluating radiation effects in red bone marrow.
Limited data are available on the effects of varying dose-rates for a given
accumulated dose (Fritz et al. 1982, 1986). The mechanisms of the con-
siderable tolerance to hemopoietic failure at low dose-rates are largely
unknown but likely linked to stem cell responses.
The analysis of revisited data in view of current knowledge allows sug-
gesting further studies on stem cell responses to low dose-rates. The out-
come also questions the justification of current radiation protection rec-
ommendations for workers as for the general public.
MATERIAL, METHODS AND OUTCOME
Human Accidental Chronic Radiation Exposure
Table 1 lists ten accidental events of chronic radiation exposure and
the incidences of death following a given duration of exposure. Figure 1
shows corresponding dose levels and clinical outcomes of some of the
exposed individuals. The given dose levels in Figure 1 are listed in mSv,
as presented in the original literature, and are here synonymous with
RBE-weighted dose, i..e., with gray-equivalent, Gy-Eq (Bolch et al. 2009;
Kutkov et al. 2011). Note that the majority of exposures were external
whole body gamma-irradiation, but exposures at the Mayak plant and at
T. M. Fliedner and others
646
TABLE 1. Selected radiation accidents and deaths, involving chronic exposure of humans to ioniz-
ing radiation. 
Accident Victims No. of Deaths Duration of Exposure
Techa (since ‘49) > 28,000 ? Lifetime
Mayak (since ‘48) > 1,800 ? several years
Mexico (1962) 5 4 24 – 115 d
Algeria (1978) 7 0 hrs – 38 d
Taiwan (since ‘82) 10,200 ? 1 – 19 y
China (1985) 3 2 150 d
Brazil (1987) 249 4 16 d
Estonia (1994) 10 1 hrs – 28 d
Moscow (1995) 1 1 ~ 150 d
Georgia (1997) 11 0 60 – 140 d
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the Techa River were both external and internal with mixed radiation
qualities and varying dose rates from internal exposure. This data set and
the individual clinical symptoms and findings have been and are helpful
for understanding the pathogenesis and clinical courses of all individual
victims (Fliedner et al. 2002a,b).
Especially revealing are the data on the exposed Techa River popula-
tion as well as the disease histories of some of the Mayak patients who suf-
fered protracted radiation exposure from external and internal radiation
sources over weeks and months working in a radiation environment
(Okladnikova and Pedsternikova 2002, Akleyev et al. 2002). Into these
groups of chronically low- dose-rate exposed people belong also the vic-
tims of accidental exposure in certain buildings in Taiwan due to the fact
that the steel used for house construction contained radioactive Co-60
that led to continuous whole body gamma exposure of the inhabitants of
these houses. Exposure in these groups, however, was not severe enough
to cause clinical complaints.
Clinical problems were recognized and described for the Mexican
accident (Martinez et al. 1966), the Algerian accident (Cosset et al. 2002),
the Chinese accident (Wang et al. 1996, Wang et al 2002), the Brazilian
accident (Valverde et al. 2002), as well as for the accidents in Estonia
Dose response, hemopoietic stem cells, adaptive protection
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FIGURE 1. Effective dose-rate (daily dose levels) in ten selected radiation accidents. Exposure times
are in days as indicated by the horizontal dotted lines. Below a dose-rate of 8.2 mSv/d beyond 150
days there was no lethality. Even after a dose-rate of 368 mSv/d for 38 days complete recovery could
be observed. This display shows the potential wide range of individual responses with the tendency
towards reconstitution with decreasing dose-rates and exposures times. 
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(Vôsumaa 2002), Moscow (Baranov 2002) and Georgia (IAEA, 2000).
Figure 1 shows the extent of daily exposures to continuous low dose-rates
and their outcome in selected victims as representatives of all listed acci-
dents.
The above data are consistent with the blood-forming tissue being the
critical site of relatively high radiosensitivity, as it is apparent clinically and
also leads to some practical clinical consequences regarding diagnosis
and therapy (IAEA 2005). For instance, after people leaving the radiation
field that causes a daily exposure to dose ranges between 80 and 100 mSv
over a period of a few months, the attending physician will be able to
observe signs of an initial recovery in the hemopoietic system of seem-
ingly healthy individuals. However, at later times and after leaving the
radiation field, as indicated in Figure 1, victims developed hematological
signs and symptoms of bone marrow failure with the risk of lethal pancy-
topenia due to myelo-proliferative disorder (MPD), or perhaps cancer, if
they survived. Noteworthy, in all these cases there was evidence for a tem-
porary hemopoietic recovery after leaving the radiation field. In the acci-
dents that occurred in China and Moscow, with continuous whole body
gamma exposures to dose-rates of 80 – 100 mSv/day for about half a year,
leukemia developed within 1.5 - 9 years after exposure.
In the Algerian accident, continuous whole-body gamma radiation
exposure was at a dose-rate of 368 mSv/day from an (unrecognized)
sealed radiation source; the exposure lasted for 38 days in four persons.
All victims developed severe pancytopenia from which they recovered
spontaneously.
In the Mexican accident, five people were continuously whole body
exposed for about 2 1/2 months to Co-60 gamma rays at dose-rates
between 160 and 320 mSv/day. These victims were not aware that the
steel capsule in their kitchen shelf contained a radiation source. Four of
these five people died from hemopoietic failure 1 – 3.5 months after
exposure. Only one person survived and showed a spontaneous hemo-
poietic recovery after exposure to 162 mSv/day. It should be stressed that
there were significant differences in the upper and lower dose estimates
in these individuals.
Such case histories may lead to the following hypotheses: in all acci-
dents with continuous whole body radiation exposures (chronic, pro-
tracted, or intermittent), the degree of tolerance or failure of the hemo-
poietic system appears to be crucial for the clinical outcome regarding
morbidity and mortality, either during or within the first few years after
exposure. If the dose-rate level is below about 10 mSv/day, human beings
can survive for several years without any organ failure. One may argue
that the survivors eventually may develop cancer or other non-malignant
diseases with the consequence of life shortening. If the dose-rate level
exceeds 10 mSv/day, the chance of developing bone marrow failure with-
T. M. Fliedner and others
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in a relatively short period of time, i.e., from weeks to years, increases
depending on exposure conditions of dose-rate and total dose and
appears individually determined. Initial recovery of hemopoietic func-
tion was a feature in all at lower dose-rates. Still, intensive studies of the
individual impairments have not yet revealed fully the patho-mechanisms
underlying the hemopoietic failure. The crucial question focuses on the
individual responses of hemopoietic stem cells to the various dose-rates
over different periods of exposure time. The capacity of stem cells for
reestablishing homeostasis in blood formation appears to span a remark-
able range of damage severity.
Experimental Animal Studies
Studies with Rats
In order to analyze the tolerance of hemopoietic cell renewal systems
systematically, extended animal studies are required. A number of such
large studies have been conducted on hemopoietic responses to chronic
whole body radiation exposures especially in rodents (Lamerton et al.
1960; Testa et al. 1973; Chu-Tse and Lajtha 1975; Gidali et al. 1979; Baird
et al. 1990). Since such studies with low-dose exposed animals have con-
siderable difficulties currently being funded, re-analyses of old data
promises to answer renewed questions on hemopoietic tolerance during
chronic low dose-rate irradiation. In the 1950s, Lamerton and his group
in London (Lamerton et al. 1960) were the first to systematically examine
the effects of protracted irradiation of the blood forming organs of the
rat. Figures 2A – 2D are taken from Lamerton et al. 1960 and show hema-
tological responses in rats following continuous whole body gamma irra-
diation using dose-rates of 1.76 Gy/day (Figure 2D), 0.84 Gy/day
(Figure 2C), 0.50 Gy/day (Figure 2B) and 0.16 Gy/day (Figure 2A). The
figures express the peripheral blood counts of platelets, mononuclear
cells, and polymorph cells as a function of time of exposure at the four
dose-rates. One can easily see that the exposures to 0.16 Gy/day and 0.50
Gy/day do not necessarily produce a lethal outcome. After initial turbu-
lences of cell counts, the hemopoietic system in rodents is apparently
capable to tolerate continuous irradiation at a certain level for some time
individually before the hemopoietic system collapses. With the assump-
tion of radiation-induced cell loss especially in the stem cell compartment
at dose-rates of 0.16 and 0.50 Gy/day, as mirrored by the initial peripher-
al blood counts, it appears that the organism tries to maintain homeosta-
sis through increased cell production that compensates for radiation-
induced cell loss.
Obviously, the hemopoietic system fails fully within less than 20 days
at 1.76 Gy/day and within about 50 days at 0.84 Gy/day. However, at this
dose-rate, an initial short-lasting rise in peripheral blood cell counts turns
to a decline to a minimum at approximately 20 days, followed by a small
Dose response, hemopoietic stem cells, adaptive protection
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FIGURE 2A. Response to continuous gamma-radiation of rats at 0.16 Gy/day. The data express
peripheral blood counts of platelets, mononuclear cells, and polymorph cells. Reproduced with per-
mission from (Lamerton et al. 1960). 
FIGURE 2B. Response to continuous gamma-radiation of rats at 0.50 Gy/day. The data express
peripheral blood counts of platelets, mononuclear cells, and polymorph cells. Reproduced with per-
mission from (Lamerton et al. 1960). 
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FIGURE 2C. Response to continuous gamma-radiation of rats at 0.84 Gy/day. The data express
peripheral blood counts of platelets, mononuclear cells, and polymorph cells. Reproduced with per-
mission from (Lamerton et al. 1960). 
FIGURE 2D. Response to continuous gamma-radiation of rats at 1.76 Gy/day. The data express
peripheral blood counts of platelets, mononuclear cells, and polymorph cells. Reproduced with per-
mission from (Lamerton et al. 1960). 
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increase in all cell counts to a maximum at about 25 days, after which the
system irreversibly tends to fail over the next 25 days. At 0.50 Gy/day, the
initial response is a short lasting rise within the first days of exposure. This
is followed by a decline in cell counts to a minimum again at about 20
days. Thereafter, the system appears capable to reestablish homeostasis
with some cell count undulations during the 200 days of observation. The
early temporary rise is hardly seen at 0.16 Gy/day where the initial drop
in cell counts reaches a minimum at about 20 days followed by recovery
to a cell count plateau of homeostasis, again with some cell count oscilla-
tions during the 300 days of observation. It is the hypothesis that the
remarkable capacity of recovery at 0.50 Gy/day and 0.16 Gy/day is, nev-
ertheless, accompanied by some functional deficit that may appear in the
cell count oscillations. This presumed deficit may be indicative of cell
kinetic adaptations in the pool of stem cells, all of which must carry dam-
age that possibly is stochastically distributed in the stem cell pool giving
rise to injured stem cell clones.
It has been postulated that the early temporary increase of viable
leukocytes, which is most pronounced at 0.80 Gy/day and least obvious at
0.16 Gy/day, is compatible with the assumption of less injured stem cells
being able to maintain cell production and deliver mature platelets and
leukocytes. This partly abortive rise is assumed to derive from injured
stem cells which disappear in the long run. Another cause of the early
temporary leucocyte increase may be a release of these cells upon an
increased distension of sinusoidal bone marrow segments associated with
parenchymal loss (Fliedner et al. 2002b,c). After 1.76 Gy/day, there is no
temporary rise but a straight forward decline of the platelets, the
mononuclear cells and the polymorphs indicating that the stem cell com-
partment has been decimated at that dose-rate.
In his original presentation in 1960, Dr. Lamerton pointed out:
“Under continuous irradiation the response of the renewal tissue of the
body may be essentially different from that under acute exposure. It is
reasonable to believe, that all the renewal tissues of the body have some
capacity for maintenance of cell populations under continuous irradia-
tion, but that they will vary greatly in the time taken for the establishment
of steady states and in the dose-rates that can be tolerated” (Lamerton et
al. 1960). Since then one has learned that the crucial cells that determine
hemopoietic responses to radiation are the blood forming stem cells,
whose individual patterns of tolerance at chronic, especially low dose-
rate, irradiations is still little understood.
Studies with Dogs
Even more revealing are the studies with dogs. These were whole-
body gamma-irradiated (from a Co-60 source) continuously throughout
life at relatively low dose-rates (Fritz et al. 1982, 1986; Seed and Meyers
1993). The dose-rates to the whole body over the entire life span were 3
T. M. Fliedner and others
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mGy/day, 7.5 mGy/day, 18.8 mGy/day, 37.5 mGy/day, 75 mGy/day and
127.5 mGy/day. Higher dose-rates of 262.5 mGy/day, 375 mGy/day and
640 mGy/day resulted in the death of all animals within 100 days. This is
the largest systematic hematological chronic irradiation study known,
where dogs were chronically exposed to radiation for their entire life-
time, i.e., until death occurred in the radiation field.
Figure 3 shows the mortality curves for the above mentioned dose-
rate groups (the figure lists dose- rates cGy/day complying with the orig-
inal publication). Irrespective of the detailed findings, these data, in gen-
eral, show a trend in responses in that a rather sudden tissue response
leading to death occurred after dose-rate dependent time intervals. Thus,
at dose rates higher than 18.8 mGy/day, death was nearly always due to
hemopoietic insufficiency in the individual groups of dogs. The higher
the dose-rates, the shorter were the time intervals, and thus the lower
were the total doses, until the issue effects occurred. Moreover, the range
Dose response, hemopoietic stem cells, adaptive protection
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FIGURE 3. Mortality curves of dogs after whole-body chronic gamma-irradiation at er dose-rates
incGy/day, adapted from (Fritz 2002). 
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of total doses that accumulated prior to onset of the tissue effect was rel-
atively broad at dose-rates of 37.5, 18.8 and 7.5 mGy/day. The relation-
ship between dose-rate and exposure time, i.e. accumulated dose, at
which the hemopoietic tissue effect developed conforms to theoretical
analyses (Scott 1980; Kutkov et al, 2011).
Within the high dose-rate groups (540 mGy/day, 375 mGy/day and
262.5 mGy/day) irradiation resulted in a lethal outcome for all animals
within a time span below 100 days of exposure. All observed deaths were
caused by hemopoietic failure. At these dose-rates, there is apparently no
chance for effective adaptation of the hemopoietic system over time to
accumulating radiation induced damage and cell loss.
In the middle dose-rate groups (127.5 mGy/day, 75 mGy/day and
37.5 mGy/day) there is a remarkable span in the survival times. While for
example in the 127.5 mGy/day group the first death occurs after about
80 days of irradiation, the last death is observed after about 1000 days.
The observed causes of death within the same dose group shift from
hemopoietic insufficiency with septicemia and aplasia to myeloprolifera-
tive disorders (MPD) and fatal tumors. Apparently there are significant
differences between individual dogs in the processes of tolerance and fail-
ure of the hemopoietic cell system during chronic radiation exposure.
In the dose-rate group 18.8 mGy/day still some dogs died from MPD,
but below this dose-rate the relative numbers of deaths from fatal tumors
increases to the level seen in control dogs. Figure 3 lists the incidence of
fatal tumors in these dose-rate groups, as described in the original litera-
ture.
Figure 4 shows examples of the blood cell concentrations of 4 dogs
during exposure to 18.8 mGy/day with MPD being the cause of death.
Over time spans that vary strongly between the individual animals, the
red blood cell concentrations appear to be nearly normal until a rather
sudden failure appears. The platelet concentrations decline slowly until
about 800 days of exposure, when disturbances set in at various times as
signals of the beginning of proliferative disorders with the eventual
hemopoietic collapse more than 500 days later. Regarding the segmented
granulocyte concentrations, the values fluctuate rather widely already
during the early days of exposure with some stabilization lasting from
about 200 to 400 days, when fluctuations aggravate again in 2 dogs, and
at later times the other 2 dogs follow this pattern. Obviously these fluctu-
ations are prodromal to the collapse of the hemopoietic system about 500
days later. These data indicate for the clinician that the examination of
the blood counts alone would probably not necessarily point to the exis-
tence and the severity of chronic radiation exposure of the subject.
In the group of 92 dogs exposed to 3 mGy/day, there were no signif-
icant changes in the concentration of red cells, platelets, and segmented
granulocytes in the individual dogs in a clinically relevant way, through-
T. M. Fliedner and others
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FIGURE 4. Example blood cell counts of 4 dogs of the cohort of whole-body chronically gamma-irra-
diated dogs, at a dose-rate of 18.8 mGy/day. Data of numbered dogs were selected from (Beagle Dog
Tissue Archive 2012). 
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out the study (Fritz et al. 1982, 1986, Fritz 2002). This indicates that under
clinical conditions the examination of the blood counts alone would not
point to a chronic radiation exposure of the subject. In fact, in this group
some dogs survived up to 5000 days, i.e., about 13 years - a full life span -
, within the radiation field. The cause of death in these dogs was similar
to the control, dominated by fatal tumor.
However, viewing the whole cohort of this group, radiation effects
aspire, in that the red cell counts tended to decline slowly with exposure
times beyond about 1000 days, the granulocyte counts in a number of
dogs became elevated temporarily at between about 1500 to 2500 days,
and the platelet counts in a number of dogs became elevated temporari-
ly at between about 1500 to 3500 days.
In summary, the above canine studies show - dependent on dose-rate
- two major causes of death: hemopoietic failure and tumors. With
decreasing low dose-rates, hemopoietic failure becomes infrequent and
finally disappears at ~ 3 mGy/day. Then, tumors become the predomi-
nant fate at a near full life span, similar to the control unirradiated dogs.
It appears to be a particular challenge to explain the reason of, and
the pathophysiological cell system effects that result in, the observed wide
range of survival times during chronic exposure. The responses of the
dogs were individually unpredictable at low dose-rates. Some of these
dogs succumbed earlier than others rather abruptly with hemopoietic
failure. This seems to indicate that individual genetic control causes indi-
vidually varying radiosensitivities in terms of capacity for tolerance or fail-
ure of the blood forming system.
Simulations of hemopoietic processes in radiation fields using mathemati-
cal models of blood cell turnover.
Simulation results showed that reductions in peripheral blood cell
concentrations as they are seen in the dog studies above at dose-rates of
more than 3 mGy/day can be explained by continuous radiation induced
excess cell losses in the stem (and precursor) cell pools of suitable math-
ematical compartment models of hemopoiesis (Graessle 2002). This stem
cell loss is combined with a compensational increase of cell production by
the remaining stem cells. Still, some questions for this type of modelling
chronic radiation effects remain unanswered. For example, during about
100 days after onset of irradiation with more than 3 mGy/ day, the con-
centrations of segmented neutrophil cells and platelets having fallen ini-
tially stabilized commensurate with homeostasis. As a consequence, the
radiation effect on the stem cells had to be modelled not only as a func-
tion of dose-rate but also as a function of exposure time, with the dose-
rates per group of dogs being constant throughout the studies. In other
words, the function of exposure time becomes a function of accumulated
dose. In biological terms this means that some characteristic radiation
T. M. Fliedner and others
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effects at the cellular level are changing during the exposure. Possible
causes could be the adaptation of the hemopoietic cell to repetitive low
dose exposures with injured stem cells acquiring the potential for main-
taining hemopoietic homeostasis, at least for some period of time. This
was considered in the approach to simulate human patient data of the
Techa River cohort (Akushevich et al. 2011). Moreover, the remarkable
maintenance of peripheral blood cell concentrations within normal
ranges – yet with a tendency to a slow steady decline of erythrocytes and
a concomitant increase of segmented neutrophil cells - over an entire life
span of dogs exposed to 3 mGy/day could be the consequence of adap-
tation of the hemopoietic system to sustain repetitive damage, with stem
cells being the pace makers.
The simulation study of Graessle (Graessle 2002) also considered a
stochastic approach of the variation of survival times between individuals.
Stochastic simulations suggested that widely varying survival times, as
derived from the dog studies, can result from small randomly appearing
variations in biological parameters, such as in radiation sensitivity or in
potential of selfreplication. Such variations do not necessarily have to
include a whole stem cell population of an individual, but could also be
caused by variations in subpopulations or fluctuations between clones of
stem cells (Abkowitz et al. 1996, Laukkanen et al. 2005), probably includ-
ing clones of radiation injured stem cells.
Implications for research
There are still wide gaps in understanding the pathological and
patho-physiological mechanisms that govern tolerance and failure of tis-
sues under chronic low-level radiation exposure. The critical cell system
to suffer first because of its radiosensitivity is the hemopoietic system. The
number of individuals that were involved in accidental chronic low-level
exposures is limited, so are the observations of low dose-rate exposed
experimental animals. In view of new radiobiological data, experimental
tools, and techniques the need of re-evaluation of the available data
seems obvious. This approach would complement mathematical models
and theoretical analyses using an advanced hazard function for varying
cell types and systems (Scott 1980) leading to recognize a defined rela-
tionship between dose-rate and the total dose in terms of exposure time
for a tissue effect to appear (Kutkov et al. 2011). The theoretically derived
data so far correspond well with the experimental results of the above dog
studies.
Pioneering in this field were the early observations presented in the
1960s by Lamerton and his group (Lamerton et al. 1960). Their results,
today, focus on the role of the stem cell pool in triggering clinical signs
and symptoms following low-level chronic radiation exposure. As
schematically seen in Figure 5, a proliferating cell system requires one
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intact cell type, the stem cell, and early progenitor cells for maintaining
cell replication and homeostasis of the system. Following irradiation, be
it acute or chronic, all cells may be affected with the stem cells and early
progenitor cells being amongst the most radiosensitive of all. At relative-
ly low doses or dose-rates, then, hundreds of stem and progenitor cell
clones may emerge carrying individual damages, as one would expect
from an “injured cell hypothesis.” The consequence would be a large
number of cell clones feeding into a wide variety of proliferating and per-
haps abnormal cell populations. To explore them may lead to far-reach-
ing results with broad translational effects also on research and practice
in oncology.
At comparatively low dose-rates, used in the dog studies (Fritz et al.
1982, 1986, Fritz 2002. Seed and Meyers 1993) the hemopoietic system
exhibited clearly a remarkable and unexpected potential for repair and
adaptation of the mammalian organism. Obviously, at low dose-rates, the
blood-forming stem cells show a great capacity to tolerate, and adapt to,
radiation injury by reconstituting an initially disturbed homeostatic cell
production rate that balances the radiation induced cell losses, depend-
ing on the accumulated dose. Indeed, it is remarkable that exposed dogs
surviving at least 3500 days at a dose- rate of 3 mGy/day accumulated
doses of more than 10 Gy without suffering cell proliferation failure and
functional breakdown. The molecular-biological mechanisms causing
stem cells to have a relatively high level tolerance and to adapt to chron-
T. M. Fliedner and others
658
FIGURE 5. Scheme of stem cells maintaining production of functional cells in tissues. Note that dif-
ferentiating, maturing and functional cells are less radiosensitive than progenitor cells including
stem cells; these again, may possess considerable differences in individual sensitivities to ionizing
radiation. 
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ic low-level damage for a given time still appear to be far from being
understood.
In order to relate cell responses to dose and dose-rate, microdosime-
try promises advantages for distinguishing between direct and non-tar-
geted effects on the low-level exposed system (ICRU 1983, ICRU 2011,
Feinendegen et al. 2011). For instance, whole body gamma-irradiation
from Co-60, as used in the dog experiments discussed above, causes each
micromass of 1 ng, i.e., the average mass of a mammalian cell, to absorb
per energy deposition event on average 0.3 mGy (ICRU 1983) with the
production of about 45 reactive oxygen species (ROS) in each hit micro-
mass (Feinendegen et al. 2011). In other words, a whole body dose of 0.3
mGy will cause each cell (ng) to be hit stochastically on average by one
event of 0.3 mGy. A whole body dose of 3 mGy then brings on average 10
energy deposition events from Co-60 gamma radiation per cell (ng). It
follows that a dose-rate of 3 mGy per day means that every cell (ng) in the
body is stochastically hit by an event on average every 2.4 hours, i.e., the
average time interval between two consecutive hits per given cell (ng) is
2.4 hours. This also means that on average during each 2.4 hours about
10 % of all cells (ng) in the exposed tissue become hit by an event, - or
all cells (ng) are hit ten times a day. The dog experiments discussed above
use this dose-rate leading to accumulated doses of more than 10 Gy over
a life time of more than 3500 days, without hemopoietic failure. In anal-
ogy, each cell (ng) of the dogs that were exposed for 3500 days to 3
mGy/day was hit 30,000 times by an energy deposition event each also
causing on average individual bursts of some 45 ROS. This attests a large
capacity of the relatively radiosensitive hemopoietic system, especially
stem and early progenitor cells, to tolerate repetitive damage throughout
life. Up-regulation of defences, repair and damage removal, also in terms
of adaptive protection, may all be involved. Regarding induction of
leukaemia, data in dogs are not available. But data in adult humans were
analysed and attributed again a most efficient defense system likely to be
responsible for the extremely low probability of ~10-14 for a lethal
leukemia to develop per energy deposition event in a hemopoietic stem
cell (Feinendegen et al. 1995).
At higher dose-rates, there appear to be individual limits of accumu-
lated doses at which stem cell failure with hemopoietic break-down
occurs, leading to death. This could be the consequence of a genetic pre-
disposition of stem cells toward a relatively increased radiosensitivity dur-
ing repetitive exposure over time. Be it as it may, selected stem and early
progenitor cells escaping lethality would deliver clones during repetitive-
ly occurring insults from chronic exposure and determine the individu-
ally observed degree of radiosensitivity and, thus, life expectancy.
The degree of spatial and temporal heterogeneity of energy deposi-
tion events in the exposed body at a dose-rate of 3 mGy/day from Co-60
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gamma radiation prompts the question of contribution of non-targeted
effects in addition to targeted effects on short- and/or long term func-
tion of stem and early progenitor cells (Morgan and Sowa 2009). One of
the non-targeted effects derives from bystander phenomena – both
potentially damaging and protecting (Mothersill and Seymour 2006).
These may be triggered theoretically by any hit cell (ng) in the exposed
body and affect stem cells. To what degree stem and early progenitor cells
are involved in bystander phenomena and how they respond is unknown
but obviously would, if known, help clarifying the capacity and mecha-
nisms of the hemopoietic system to tolerate and adapt to low dose-rates.
Another question in this context addresses genomic instability (Kadhim
et al. 2006). This phenomenon usually is discussed in the context of onco-
genesis in the descendants of irradiated precursor cells. However, genom-
ic instability may perhaps develop in progenitor cells also in the course of
time at low dose-rates and switch gene expression in descendant cells to
a state of up-regulated protection. The latter may enable stem and early
progenitor cells to acquire tolerance and become adapted to repetitive
energy depositions with their bursts of ROS.
The questions of direct and non-targeted responses of stem cells at
chronic low-dose irradiation may be answered in the near future. The
new techniques of isolating stem cells may open the avenue to study these
cells and their responses to injury separately from those of multi-cellular
systems.
New data from such studies may lead also to practical consequences
in the therapy of radiation syndromes and also for choosing optimal radi-
ation- and chemotherapy, for instance, in oncology.
IMPLICATIONS FOR CLINICAL PRACTICE
The current data analyses predict that an individual may spend days,
weeks or even months in a radiation field without becoming alarmed. If
a clinician finds hematological changes that are not readily explained, he
should examine for the possibility of a radiation exposure being the rea-
son for the hematological abnormalities. This scenario demands special
expertise and guidance for diagnosis and therapy also considering stem
cell transplantation (IAEA 2005; Fliedner et al. 2002a, 2009, Azzam et al.
2010; Ende and Azzam 2011).
IMPLICATIONS FOR RADIATION PROTECTION
The data presented and discussed above also touch the question of
dose limits in radiation protection in different scenarios of chronic expo-
sures. Current dose limits are fixed numbers without much attention to
dose-rate. The concept of dose-rate should be built into the exposure lim-
its. A special case is that of exponentially decreasing dose-rates over time
from internal radionuclide exposures, such as following accidental
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radionuclide intake or planned in nuclear medicine. Thus, certain mar-
row progenitor cells (GM-CFC) respond to exponentially decreasing
dose-rates specifically and show corresponding dose-rate profiles which
also should be considered (Goddu et al. 1998, 2000).
There is a great discrepancy between recommended dose rate limits,
for instance, of 1 mGy/year for the general public, on the one hand and,
on the other hand, the observed dose rate of 3 mGy/day at which the
hemopoietic system keeps providing homeostasis and full function in the
service to the whole body. Even if the two endpoints, tissue effects regard-
ing blood formation, and stochastic effects regarding tumor develop-
ment, need separate assessments, the by three orders of magnitude lower
recommended dose-rate limit for the general public compared with the
experimental dose-rate in dogs, at which the hemopoietic system still
maintains full function without apparent radiation-induced increase in
tumor incidence, questions the justification of the radioprotection rec-
ommendations. Usually, radioprotection recommendations are based on
risk coefficients derived from linear extrapolation of tumor risk observed
at high doses to low doses. This, however, appears incompatible with the
current data in dogs showing an at least three orders of magnitude lower
risk of hemopoietic failure without an apparent increase in tumor risk
per unit accumulated dose from chronic exposure. This assessment, in
fact, supports the notion that the linear-no-threshold hypothesis is invalid
and in need of adjustment (Feinendegen et al. 2011, Tanooka 2011).
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